Skip to Content
Merck
CN

936391

Fmoc-Gly-Gly-OH

≥95%

Synonym(s):

2-[2-([[(9H-Fluoren-9-yl)methoxy]carbonyl]amino)acetamido]acetic acid, N-9-Fluorenylmethoxycarbonylglycylglycine, N-Fluorenylmethoxycarbonylglycylglycine, N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycine (ACI), Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycyl- (9CI, ACI), Glycine, N-[N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycyl]- (ZCI)

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C19H18N2O5
CAS Number:
Molecular Weight:
354.36
UNSPSC Code:
12352106
NACRES:
NA.22
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥95%

form

powder or crystals

color

white to off-white

storage temp.

2-8°C

SMILES string

O=C(OCC1C=2C=CC=CC2C=3C=CC=CC31)NCC(=O)NCC(=O)O

InChI

1S/C19H18N2O5/c22-17(20-10-18(23)24)9-21-19(25)26-11-16-14-7-3-1-5-12(14)13-6-2-4-8-15(13)16/h1-8,16H,9-11H2,(H,20,22)(H,21,25)(H,23,24)

InChI key

FBKUOPULLUJMOC-UHFFFAOYSA-N

Application

Fmoc-Gly-Gly-OH is a lysosomally cleavable linker used in construction of antibody-drug conjugates (ADC & Bioconjugation).

Other Notes

Chemical Biology Tools

http://pubs.rsc.org/en/Content/ArticleLanding/2011/MB/C0MB00074D#!divAbstract


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Alain Beck et al.
Nature reviews. Drug discovery, 16(5), 315-337 (2017-03-18)
Antibody-drug conjugates (ADCs) are one of the fastest growing classes of oncology therapeutics. After half a century of research, the approvals of brentuximab vedotin (in 2011) and trastuzumab emtansine (in 2013) have paved the way for ongoing clinical trials that



Global Trade Item Number

SKUGTIN
936391-100MG04065270731012
936391-50MG04065270731029